2023
DOI: 10.1097/grf.0000000000000797
|View full text |Cite
|
Sign up to set email alerts
|

First Trimester Ultrasound and Aneuploidy Screening in Twins

Abstract: All patients with twin pregnancy should have first trimester ultrasound and be offered screening for chromosomal aneuploidy as well as diagnostic testing. Screening for aneuploidy in twins presents unique challenges compared with singletons. Cell-free DNA screening should be considered first-line; however, this option may not be available or may have limitations in certain clinical scenarios, such as vanishing twins. If cell-free DNA screening is not available, maternal serum marker screening in conjunction wi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 25 publications
0
1
0
Order By: Relevance
“…20 As patients with high-risk screening results are typically counseled to undergo confirmatory diagnostic testing, a high false-positive rate can lead to unnecessary invasive diagnostic procedures which may have a higher risk of loss in twin pregnancies. 27 As our study has shown, NIPT offers patients with twin pregnancies a more accurate approach to screen for fetal trisomies, in particular for trisomy 21. Based on known clinical outcomes, we observed both a sensitivity and specificity of > 99.9% for trisomy 21.…”
Section: Discussionmentioning
confidence: 81%
“…20 As patients with high-risk screening results are typically counseled to undergo confirmatory diagnostic testing, a high false-positive rate can lead to unnecessary invasive diagnostic procedures which may have a higher risk of loss in twin pregnancies. 27 As our study has shown, NIPT offers patients with twin pregnancies a more accurate approach to screen for fetal trisomies, in particular for trisomy 21. Based on known clinical outcomes, we observed both a sensitivity and specificity of > 99.9% for trisomy 21.…”
Section: Discussionmentioning
confidence: 81%